Abstract
In this issue of Blood, Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2601-2602 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 131 |
| Issue number | 24 |
| DOIs | |
| State | Published - Jun 14 2018 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology